Get started
Author

Birgit Bremer

Late HDV RNA Relapse After Peginterferon Alpha-Based Therapy of Chronic Hepatitis Delta
2014 · Benjamin Heidrich, Cihan Yurdaydın, et al. · Hepatology · 301
PDF
A Mutation in the Hepatitis E Virus RNA Polymerase Promotes Its Replication and Associates With Ribavirin Treatment Failure in Organ Transplant Recipients
2014 · Yannick Debing, Anett Gisa, et al. · Gastroenterology · 213
PDF
Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients
2009 · Sven Pischke, Pothakamuri V. Suneetha, et al. · Liver Transplantation · 196
PDF
In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome
2016 · Daniel Todt, Anett Gisa, et al. · Gut · 187
PDF
Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection
2011 · Pothakamuri Venkata Suneetha, Sven Pischke, et al. · Hepatology · 180
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial
2022 · Heiner Wedemeyer, Katrin Schöneweis, et al. · The Lancet Infectious Diseases · 166
Chronic Hepatitis E in Heart Transplant Recipients
2012 · S. Pischke, P. Stiefel, et al. · American Journal of Transplantation · 156
Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D
2015 · B. Maasoumy, S.B. Wiegand, et al. · Clinical Microbiology and Infection · 148
Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection
2018 · H. Wedemeyer, P. Bogomolov, et al. · Journal of Hepatology · 127
GS-13-Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infection
2019 · Heiner Wedemeyer, Katrin Schöneweis, et al. · Journal of Hepatology · 123
Compromised Function of Natural Killer Cells in Acute and Chronic Viral Hepatitis
2013 · Sebastian Lunemann, David F. G. Malone, et al. · The Journal of Infectious Diseases · 122
Antiviral treatment and liver‐related complications in hepatitis delta
2016 · Anika Wranke, Beatriz Calle Serrano, et al. · Hepatology · 117
Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection
2021 · Elmira Aliabadi, Melanie Urbanek-Quaing, et al. · Gut · 99
Establishment of a Novel Quantitative Hepatitis D Virus (HDV) RNA Assay Using the Cobas TaqMan Platform To Study HDV RNA Kinetics
2010 · Ingmar Mederacke, Birgit Bremer, et al. · Journal of Clinical Microbiology · 94
Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation
2011 · Ingmar Mederacke, Natalie Filmann, et al. · Journal of Hepatology · 82
Hepatitis E Virus (HEV) ORF2 Antigen Levels Differentiate Between Acute and Chronic HEV Infection
2016 · Patrick Behrendt, Birgit Bremer, et al. · The Journal of Infectious Diseases · 72
Development and evaluation of a baseline‐event‐anticipation score for hepatitis delta
2014 · B. Calle Serrano, A. Großhennig, et al. · Journal of Viral Hepatitis · 71
PDF
Increased HEV Seroprevalence in Patients with Autoimmune Hepatitis
2014 · Sven Pischke, Anett Gisa, et al. · PLoS ONE · 70
PDF
Anti-HDV IgM as a Marker of Disease Activity in Hepatitis Delta
2014 · Anika Wranke, Benjamin Heidrich, et al. · PLoS ONE · 68
PDF
Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens
2016 · Benjamin Maasoumy, Johannes Vermehren, et al. · Journal of Hepatology · 66
Hepatitis E virus replication and interferon responses in human placental cells
2018 · Leonard Knegendorf, Svenja A. Drave, et al. · Hepatology Communications · 64
PDF
Effects of HDV infection and pegylated interferon α treatment on the natural killer cell compartment in chronically infected individuals
2014 · Sebastian Lunemann, David F G Malone, et al. · Gut · 59
Non‐invasive fibrosis score for hepatitis delta
2016 · Gunnar L. Lutterkort, Anika Wranke, et al. · Liver International · 57
HB eAg‐positive hepatitis delta: virological patterns and clinical long‐term outcome
2012 · Benjamin Heidrich, Beatriz C. Serrano, et al. · Liver International · 55
Chronic hepatitis E in hematopoietic stem cell transplant patients in a low‐endemic country?
2011 · C. Koenecke, S. Pischke, et al. · Transplant Infectious Disease · 44
Works count: 160
Citation count: 3,824
H-index: 32
I10-index: 56
Year
Topic
Type